Class information for:
Level 1: EGFRVIII//RECURRENT GLIOBLASTOMA//TUMOR TREATING FIELDS

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
6320 1434 51.0 89%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
128 23028 EPENDYMOMA//MEDULLOBLASTOMA//GLIOBLASTOMA

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 EGFRVIII Author keyword 61 53% 6% 80
2 RECURRENT GLIOBLASTOMA Author keyword 22 49% 2% 33
3 TUMOR TREATING FIELDS Author keyword 21 90% 1% 9
4 P TON ROBERT TI BRAIN TUMOR Address 10 22% 3% 39
5 ONCOGEN SIGNALLING Address 7 57% 1% 8
6 STEPHEN E CATHERINE P PAS NEUROONCOL Address 7 31% 1% 18
7 NOVOTTF 100A Author keyword 6 80% 0% 4
8 NEUROONCOL BRANCH Address 6 19% 2% 29
9 DELTA EGFR Author keyword 6 100% 0% 4
10 TEMOZOLOMIDE REFRACTORY Author keyword 6 100% 0% 4

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 EGFRVIII 61 53% 6% 80 Search EGFRVIII Search EGFRVIII
2 RECURRENT GLIOBLASTOMA 22 49% 2% 33 Search RECURRENT+GLIOBLASTOMA Search RECURRENT+GLIOBLASTOMA
3 TUMOR TREATING FIELDS 21 90% 1% 9 Search TUMOR+TREATING+FIELDS Search TUMOR+TREATING+FIELDS
4 NOVOTTF 100A 6 80% 0% 4 Search NOVOTTF+100A Search NOVOTTF+100A
5 DELTA EGFR 6 100% 0% 4 Search DELTA+EGFR Search DELTA+EGFR
6 TEMOZOLOMIDE REFRACTORY 6 100% 0% 4 Search TEMOZOLOMIDE+REFRACTORY Search TEMOZOLOMIDE+REFRACTORY
7 RECURRENT MALIGNANT GLIOMA 5 41% 1% 9 Search RECURRENT+MALIGNANT+GLIOMA Search RECURRENT+MALIGNANT+GLIOMA
8 HIGH GRADE GLIOMA 4 11% 3% 36 Search HIGH+GRADE+GLIOMA Search HIGH+GRADE+GLIOMA
9 RECURRENT GLIOBLASTOMA MULTIFORME 3 40% 0% 6 Search RECURRENT+GLIOBLASTOMA+MULTIFORME Search RECURRENT+GLIOBLASTOMA+MULTIFORME
10 RINDOPEPIMUT 3 50% 0% 4 Search RINDOPEPIMUT Search RINDOPEPIMUT

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 SINGLE AGENT BEVACIZUMAB 123 81% 5% 75
2 BRAIN TUMOR CONSORTIUM 111 64% 8% 109
3 BEVACIZUMAB PLUS IRINOTECAN 71 44% 8% 120
4 CONFERS ENHANCED TUMORIGENICITY 62 56% 5% 75
5 RECURRENT MALIGNANT GLIOMA 48 32% 9% 127
6 RECURRENT GLIOBLASTOMA 40 27% 9% 126
7 NEWLY DIAGNOSED GLIOBLASTOMA 39 22% 11% 157
8 NEURO ONCOLOGIA GICNO 35 89% 1% 16
9 HIGH GRADE GLIOMAS 34 15% 14% 200
10 RECURRENT GLIOBLASTOMA MULTIFORME 20 25% 5% 69

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Standards of care for treatment of recurrent glioblastoma-are we there yet? 2013 54 99 62%
Bevacizumab and Glioblastoma: Scientific Review, Newly Reported Updates, and Ongoing Controversies 2015 1 63 73%
Malignant gliomas in adults 2008 1103 102 18%
Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end? 2013 64 135 28%
The EGFRvIII variant in glioblastoma multiforme 2009 117 96 69%
Timing of surgery and bevacizumab therapy in neurosurgical patients with recurrent high grade glioma 2015 1 33 45%
Epidermal growth factor receptor: a re-emerging target in glioblastoma 2012 31 41 61%
The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered 2013 20 226 54%
Pathway inhibition: emerging molecular targets for treating glioblastoma 2011 58 75 45%
Drug Review: Safety and Efficacy of Bevacizumab for Glioblastoma and Other Brain Tumors 2013 17 99 57%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 P TON ROBERT TI BRAIN TUMOR 10 22% 2.7% 39
2 ONCOGEN SIGNALLING 7 57% 0.6% 8
3 STEPHEN E CATHERINE P PAS NEUROONCOL 7 31% 1.3% 18
4 NEUROONCOL BRANCH 6 19% 2.0% 29
5 HENRY E SINGLETON BRAIN TUMOR PROGRAM 5 54% 0.5% 7
6 CANC NEUROL 4 44% 0.5% 7
7 EPITHELIAL BIOCHEM 4 46% 0.4% 6
8 TUMOR TARGETING PROGRAM 3 50% 0.3% 5
9 SECT 6321 3 33% 0.6% 8
10 SAN DIEGO BRANCH 3 22% 0.8% 12

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000232672 TEMOZOLOMIDE//GLIOBLASTOMA MULTIFORME//ANAPLASTIC ASTROCYTOMA
2 0.0000191848 IDH1//IDH2//ISOCITRATE DEHYDROGENASE 1
3 0.0000180505 BRAIN TUMOR STEM CELL//GLIOMA STEM CELLS//BRAIN TUMOR STEM CELLS
4 0.0000128402 MTIC//DIPARTIMENTO FARMACOCHIM TOSSICOL BIOL//VLAK PROTOCOL
5 0.0000121872 OLIGODENDROGLIOMA//OLIGOASTROCYTOMA//19Q
6 0.0000117745 PSEUDOPROGRESSION//GLIOMA GRADING//MACDONALD CRITERIA
7 0.0000111149 HUMAN MALIGNANT GLIOMAS//MOL EXPT RADIOL//RADGENOM GRP
8 0.0000100434 NIMOTUZUMAB//H R3//CETUXIMAB
9 0.0000082993 CONVECTION ENHANCED DELIVERY//GLIADEL//CARMUSTINE WAFERS
10 0.0000082940 EGF DEXTRAN//ANTIBODY BINDING PARAMETERS//BIOMED RADIAT SCI